Insiders · Profile

Girao Tiago

Chief Financial Officer at Immunovant · VP & Chief Financial Officer at CERENOME. Filing since 11 Nov 2014. CIK 0001618670

Company
Date
Role
Action
Shares
Amount
Of holding
23 Jul 2026
Chief Financial Officer
Sold at will
6,798
$263.01K
2.7%
26 Jun 2026
Chief Financial Officer
Sold at will
10,000
$384.60K
3.9%
23 Apr 2026
Chief Financial Officer
Sold at will
25,760
$763.01K
9.4%
18 Aug 2015
VP & Chief Financial Officer
Bought
25,000
$9.75K
39.7%
12 Nov 2014
VP & Chief Financial Officer
Bought
44,111
$17.20K
278%
11 Nov 2014
VP & Chief Financial Officer
Bought
15,889
$6.20K
opened
6 decisions on file.